Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multicentre randomised placebo controlled clinical trial of metformin versus placebo in pregnant women to reduce the risk of obesity and metabolic syndrome in their babies.

Trial Profile

A multicentre randomised placebo controlled clinical trial of metformin versus placebo in pregnant women to reduce the risk of obesity and metabolic syndrome in their babies.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 10 Oct 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Metformin (Primary)
  • Indications Metabolic syndrome; Obesity
  • Focus Registrational; Therapeutic Use
  • Acronyms EMPOWaR

Most Recent Events

  • 13 Aug 2015 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network record.
  • 05 Nov 2014 Planned End Date changed from 31 Jan 2014 to 30 Apr 2015, according to ISRCTN: Current Controlled Trials.
  • 07 Feb 2014 Accrual to date is 112% according to United Kingdom Clinical Research Network record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top